These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 3817343)
21. Etretinate (Tigason) for skin disease. Drug Ther Bull; 1983 Feb; 21(3):9-11. PubMed ID: 6839967 [No Abstract] [Full Text] [Related]
22. Joint pains with psoriasis and long-term systemic etretinate therapy: a case report and summary of 12 cases. Ishida Y; Ozawa A; Ohkido M; Imai N J Dermatol; 1993 Oct; 20(10):651-3. PubMed ID: 8277044 [TBL] [Abstract][Full Text] [Related]
23. Thrombocytopenia associated with etretinate therapy. Liang R Acta Haematol; 1988; 79(2):112-3. PubMed ID: 3124469 [TBL] [Abstract][Full Text] [Related]
24. Combination of etretinate with cyclosporine in the treatment of severe recalcitrant psoriasis. Brechtel B; Wellenreuther U; Toppe E; Czarnetzki BM J Am Acad Dermatol; 1994 Jun; 30(6):1023-4. PubMed ID: 8188867 [No Abstract] [Full Text] [Related]
25. Peripheral neuropathy during etretinate therapy for psoriasis. Hammer CJ; Carter CC; Hanifin JM J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):272-3. PubMed ID: 8381828 [No Abstract] [Full Text] [Related]
26. The retinoids, Part II. Long K; Long R Nurse Pract Forum; 1995 Jun; 6(2):60-1. PubMed ID: 7620395 [No Abstract] [Full Text] [Related]
27. Hepatotoxic reactions in a patient treated with etretinate. Weiss VC; West DP; Ackerman R; Robinson LA Arch Dermatol; 1984 Jan; 120(1):104-6. PubMed ID: 6691707 [TBL] [Abstract][Full Text] [Related]
28. [Skeletal changes caused by etretinate]. Crespi HG; Massimo JA; Gentile F; Cordero AA Med Cutan Ibero Lat Am; 1986; 14(2):77-81. PubMed ID: 3528712 [TBL] [Abstract][Full Text] [Related]
29. A three-year follow-up study of psoriasis patients treated with low dosages of etretinate orally and corticosteroids topically. Polano MK; van der Rhee HJ; van der Schroeff JG Acta Derm Venereol; 1982; 62(4):361-4. PubMed ID: 6183880 [TBL] [Abstract][Full Text] [Related]
30. [Vertebral hyperostosis induced by etretinate]. Hans P; Pompougnac E; Barucq JP; Barucq P; Beylot C Rev Rhum Mal Osteoartic; 1988 Dec; 55(12):1027-9. PubMed ID: 3238301 [No Abstract] [Full Text] [Related]
31. [Pustular psoriasis: the appearance of Lyell's syndrome and a lymphoblastic transformation test positive to Ro 10-9359]. Oleffe J; de Bast C; Van Opdenbosch L; De Coninck A Dermatologica; 1982 Nov; 165(5):446-9. PubMed ID: 7169116 [No Abstract] [Full Text] [Related]
33. Methotrexate and etretinate as concurrent therapies in severe psoriasis. Vanderveen EE; Ellis CN; Campbell JP; Case PC; Voorhees JJ Arch Dermatol; 1982 Sep; 118(9):660-2. PubMed ID: 7114868 [TBL] [Abstract][Full Text] [Related]
34. Serial liver biopsies in psoriatic patients receiving long-term etretinate. Roenigk HH; Gibstine C; Glazer S; Sparberg M; Yokoo H Br J Dermatol; 1985 Jan; 112(1):77-81. PubMed ID: 3970836 [TBL] [Abstract][Full Text] [Related]
35. Isotretinoin vs etretinate therapy in generalized pustular and chronic psoriasis. Moy RL; Kingston TP; Lowe NJ Arch Dermatol; 1985 Oct; 121(10):1297-301. PubMed ID: 3862363 [TBL] [Abstract][Full Text] [Related]
36. Increased muscle tone during etretinate therapy. Ellis CN; Gilbert M; Cohen KA; Albers JW; Ball RD; Albin RL; Silverman A; Voorhees JJ J Am Acad Dermatol; 1986 May; 14(5 Pt 2):907-9. PubMed ID: 3711400 [TBL] [Abstract][Full Text] [Related]
37. Etretinate-induced heterotopic bone formation about the hip joint. A case report including ultrastructural study. Inoue K; Imai S; Iwasaki A; Egawa M; Hukuda S Clin Orthop Relat Res; 1994 Nov; (308):139-45. PubMed ID: 7955675 [TBL] [Abstract][Full Text] [Related]